Can't find Baricitinib (Olumiant) at your pharmacy? Here are proven tools and tips to locate Baricitinib in stock near you in 2026, including real-time search.
You need your medication. Your doctor prescribed Baricitinib (Olumiant) for a reason — whether it's rheumatoid arthritis, alopecia areata, or another condition — and going without it isn't an option. But when you call your pharmacy and hear "we don't have it in stock," panic can set in fast.
The good news: Baricitinib is available. You just need to know where to look and how to navigate the system. In this guide, we'll share practical tools and tips to help you find Baricitinib in stock near you.
Before we get into solutions, it helps to understand the problem. Baricitinib is a specialty medication that costs around $2,500 to $3,000 per month. Most retail pharmacies don't keep it on the shelf because:
For a deeper dive into why this medication is hard to find, read our full explainer.
The fastest way to find Baricitinib in stock is to use Medfinder. Medfinder shows you real-time pharmacy availability so you don't have to call around to dozens of pharmacies yourself.
Here's how it works:
This saves you time, frustration, and the anxiety of not knowing where to turn. You can also use Medfinder to check if a specific pharmacy has Baricitinib.
Big chain pharmacies (CVS, Walgreens, Rite Aid) often don't stock specialty medications like Baricitinib. But that doesn't mean nobody has it. Consider these alternatives:
Locally owned pharmacies sometimes have more flexibility in what they stock and can order specialty medications faster. They may also provide more personalized service and be willing to work with your insurance on prior authorizations.
Your insurance plan likely has a preferred specialty pharmacy network. These pharmacies specifically handle high-cost medications like Baricitinib and can ship them directly to your home. Common specialty pharmacies include:
Ask your insurance company which specialty pharmacy is in your network. Many will ship Baricitinib to your door within a few business days.
If you receive care at an academic medical center or large health system, their outpatient pharmacy may stock Baricitinib, especially if they have a rheumatology or dermatology department.
Specialty medications like Baricitinib often require advance planning. Here are some timing tips:
If you've tried the tips above and still can't locate Baricitinib, here are additional steps:
As the manufacturer of Olumiant, Eli Lilly can help connect you with pharmacies that have stock available. They may also be able to provide your medication through their patient support programs. Call 1-800-545-5979 for assistance.
If access remains a problem, your doctor may be able to prescribe a similar JAK inhibitor like Tofacitinib (Xeljanz), Upadacitinib (Rinvoq), or Ritlecitinib (Litfulo). Read our alternatives guide to learn about your options.
Sometimes the issue isn't availability — it's affordability. If cost is preventing you from filling your prescription, check out our guide on how to save money on Baricitinib, including manufacturer savings cards and patient assistance programs.
If there will be a gap before you can get Baricitinib, ask your doctor whether any short-term treatment adjustments are appropriate. Do not stop taking Baricitinib without your doctor's guidance.
Finding Baricitinib in stock takes a bit more effort than picking up a common medication, but it's absolutely doable. Use Medfinder to check real-time availability, explore specialty pharmacy options, and plan your refills ahead of time.
If you're a healthcare provider looking to help your patients find Baricitinib, check out our provider's guide.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
